AVTX
Avalo Therapeutics Inc
13.70$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2,896.6% | -484.4% | – | – | -4,629.3% | -7,835.4% | – | – | – | -24,145.8% | – | – | -112,505.1% | |
| 17.4% | 7.5% | – | – | 13.7% | 35.4% | – | – | – | 27.1% | – | – | 184.7% | |
| 403.8% | 135.9% | – | – | 742.2% | 1,512.5% | – | – | – | 7,640.7% | – | – | 28,037.3% | |
| -1,541.9% | 14.9% | – | – | -605.2% | -318.8% | – | – | – | 298.3% | – | – | 1,596.6% | |
| 0.0% | 27.7% | – | – | 0.0% | 0.0% | – | – | – | 0.0% | – | – | 0.0% | |
| – | -27.7% | – | – | – | – | – | – | – | 4,069.5% | – | – | -534,372.9% | |
| – | 11.7% | – | – | – | – | – | – | – | -28.8% | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 4,531.8% | 0.2% | – | – | 0.0% | 35,265.1% | – | – | – | 1,164.4% | – | – | 1,450,622.0% | |
| 1,635.2% | -484.2% | – | – | -4,629.3% | 27,430.2% | – | – | – | -18,911.9% | – | – | 803,744.1% | |
| -2,896.6% | -512.1% | – | – | -4,629.3% | -7,835.4% | – | – | – | -24,145.8% | – | – | -112,505.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.